Astrana Long Term Debt vs Net Working Capital Analysis
ASTH Stock | 33.48 0.01 0.03% |
Astrana Health financial indicator trend analysis is way more than just evaluating Astrana Health prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Astrana Health is a good investment. Please check the relationship between Astrana Health Long Term Debt and its Net Working Capital accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Astrana Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. For more detail on how to invest in Astrana Stock please use our How to Invest in Astrana Health guide.
Long Term Debt vs Net Working Capital
Long Term Debt vs Net Working Capital Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Astrana Health Long Term Debt account and Net Working Capital. At this time, the significance of the direction appears to have almost identical trend.
The correlation between Astrana Health's Long Term Debt and Net Working Capital is 0.94. Overlapping area represents the amount of variation of Long Term Debt that can explain the historical movement of Net Working Capital in the same time period over historical financial statements of Astrana Health, assuming nothing else is changed. The correlation between historical values of Astrana Health's Long Term Debt and Net Working Capital is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Long Term Debt of Astrana Health are associated (or correlated) with its Net Working Capital. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Working Capital has no effect on the direction of Long Term Debt i.e., Astrana Health's Long Term Debt and Net Working Capital go up and down completely randomly.
Correlation Coefficient | 0.94 |
Relationship Direction | Positive |
Relationship Strength | Very Strong |
Long Term Debt
Long-term debt is a debt that Astrana Health has held for over one year. Long-term debt appears on Astrana Health balance sheet and also includes long-term leases. The most common forms of long term debt are bonds payable, long-term notes payable, mortgage payable, pension liabilities, and lease liabilities. In the corporate world, long-term debt is generally used to fund big-ticket items, such as machinery, buildings, and land. The total of long-term debt reported on Astrana Health balance sheet is the sum of the balances of all categories of long-term debt. Debt that is not due within the current year and is often considered to be financing activities that are to be repaid over several years.Net Working Capital
Most indicators from Astrana Health's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Astrana Health current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Astrana Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. For more detail on how to invest in Astrana Stock please use our How to Invest in Astrana Health guide.The Astrana Health's current Selling General Administrative is estimated to increase to about 118.2 M, while Tax Provision is projected to decrease to under 22.8 M.
2021 | 2022 | 2023 | 2024 (projected) | Cost Of Revenue | 596.1M | 944.7M | 1.2B | 1.2B | Total Revenue | 773.9M | 1.1B | 1.4B | 1.5B |
Astrana Health fundamental ratios Correlations
Click cells to compare fundamentals
Astrana Health Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Astrana Health fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 728.7M | 817.5M | 867.4M | 966.2M | 933.4M | 980.0M | |
Other Current Liab | 77.0M | 74.1M | 88.5M | 128.5M | 184.1M | 193.3M | |
Total Current Liabilities | 105.4M | 115.0M | 114.7M | 148.6M | 218.7M | 229.6M | |
Total Stockholder Equity | 191.5M | 330.8M | 448.2M | 542.6M | 614.2M | 644.9M | |
Net Debt | 153.3M | 67.1M | (32.1M) | (58.7M) | 27.2M | 28.6M | |
Retained Earnings | 31.9M | 69.8M | 137.2M | 182.4M | 243.1M | 255.3M | |
Accounts Payable | 6.9M | 9.6M | 5.5M | 10.5M | 9.1M | 9.5M | |
Cash | 103.3M | 193.5M | 233.1M | 288.0M | 293.8M | 308.5M | |
Cash And Short Term Investments | 219.8M | 261.2M | 286.5M | 293.6M | 296.3M | 311.1M | |
Common Stock Total Equity | 35.9K | 42K | 45K | 47K | 54.1K | 30.0K | |
Common Stock Shares Outstanding | 36.4M | 37.4M | 45.4M | 45.6M | 47.1M | 49.4M | |
Liabilities And Stockholders Equity | 728.7M | 817.5M | 867.4M | 966.2M | 933.4M | 980.0M | |
Non Current Liabilities Total | 262.2M | 257.3M | 242M | 259.1M | 303.9M | 319.1M | |
Other Stockholder Equity | 159.6M | 261.0M | 310.9M | 360.1M | 371.0M | 389.6M | |
Total Liab | 367.7M | 372.3M | 356.7M | 407.7M | 522.6M | 548.7M | |
Total Current Assets | 329.1M | 338.6M | 404.5M | 428.1M | 461.5M | 484.6M | |
Common Stock | 35.9K | 42K | 45K | 47K | 54.1K | 33.4K | |
Short Long Term Debt Total | 256.6M | 260.6M | 201.0M | 229.4M | 321.0M | 337.1M | |
Short Term Debt | 12.6M | 14.2M | 3.9M | 4.8M | 24.8M | 26.0M | |
Property Plant And Equipment Net | 26.4M | 48.5M | 68.6M | 129.0M | 44.6M | 23.8M | |
Non Current Assets Total | 399.6M | 478.9M | 462.9M | 538.1M | 471.9M | 495.4M | |
Non Currrent Assets Other | 1.7M | 19.4M | 5.9M | 4.6M | 44.6M | 46.9M | |
Net Receivables | 99.0M | 60.6M | 99.3M | 119.7M | 147.8M | 155.1M | |
Other Current Assets | 10.3M | 16.8M | 18.6M | 14.8M | 17.5M | 18.3M | |
Property Plant And Equipment Gross | 26.4M | 48.5M | 68.6M | 129.0M | 67.4M | 70.8M | |
Net Tangible Assets | 18.8M | 119.0M | 118.7M | 214.0M | 246.1M | 258.4M | |
Current Deferred Revenue | 8.9M | 13.0M | 16.8M | 531K | 744K | 706.8K | |
Noncontrolling Interest In Consolidated Entity | 786.2K | 87K | 5.9M | 2.2M | 2.5M | 1.8M | |
Other Assets | 2.4M | 55.3M | 6.5M | 6.1M | 22.1M | 12.9M | |
Long Term Debt | 232.2M | 230.2M | 182.9M | 203.4M | 258.9M | 271.9M | |
Good Will | 238.5M | 239.1M | 246.4M | 269.1M | 278.8M | 139.8M | |
Retained Earnings Total Equity | 31.9M | 69.8M | 143.6M | 192.7M | 221.6M | 232.7M | |
Short Term Investments | 116.5M | 67.7M | 53.4M | 5.6M | 2.5M | 2.4M | |
Long Term Debt Total | 232.2M | 230.2M | 182.9M | 203.4M | 233.9M | 245.6M | |
Capital Surpluse | 159.6M | 261.0M | 310.9M | 360.1M | 414.1M | 434.8M | |
Deferred Long Term Liab | 18.3M | 11.0M | 9.1M | 3.0M | 3.5M | 6.8M | |
Intangible Assets | 103.0M | 87.0M | 82.8M | 76.9M | 71.6M | 56.4M |
Currently Active Assets on Macroaxis
When determining whether Astrana Health offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Astrana Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Astrana Health Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Astrana Health Stock:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Astrana Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. For more detail on how to invest in Astrana Stock please use our How to Invest in Astrana Health guide.You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Astrana Health. If investors know Astrana will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Astrana Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.30) | Earnings Share 1.3 | Revenue Per Share 36.415 | Quarterly Revenue Growth 0.375 | Return On Assets 0.0449 |
The market value of Astrana Health is measured differently than its book value, which is the value of Astrana that is recorded on the company's balance sheet. Investors also form their own opinion of Astrana Health's value that differs from its market value or its book value, called intrinsic value, which is Astrana Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Astrana Health's market value can be influenced by many factors that don't directly affect Astrana Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Astrana Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Astrana Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Astrana Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.